DSUK Conference – Professional Day

Biocodex, Encoded Therapeutics, Harmony Biosciences, Jazz Pharmaceuticals and Stoke Therapeutics have all provided sponsorship funding to DSUK in support of the Biennial Professional Day Conference. These organisations have had no involvement in the development of the conference agenda, or any of its content.

The Dravet Syndrome UK Conference for healthcare professionals will take place from 9am to 4pm on Friday 14th November, in-person at the Hotel Pullman, London St Pancras, and virtually, online.

The conference includes a packed agenda of leading voices in Dravet Syndrome to enable discussion of the latest updates, news and medical research. In attending this conference, healthcare professionals can expect to achieve the following:

Increased understanding of Dravet Syndrome
Better understanding of how and when to diagnose Dravet Syndrome
Improved awareness and understanding of current treatments for Dravet Syndrome
Improved understanding of the associated co-morbidities of Dravet Syndrome and its natural history
Better understanding of SUDEP and other associated mortality in Dravet Syndrome
Improved awareness and understanding of emerging treatments for Dravet Syndrome
Increased understanding of findings in research relating to Dravet Syndrome

Read our event Terms and Conditions here.

"I'll be able to use new knowledge gained from a very informative and interesting day, when caring for my patient, and will have further understanding if I have a newly diagnosed child living with Dravet Syndrome join my caseload."

Attendee, DSUK Conference 2023

Read the Professionals Day Conference Agenda

Read the agenda

Register for our In-Person Professional Day Conference

Register to virtually attend our Professional Day Conference

Are you a Parent/Carer of someone living with Dravet Syndrome?

Why not register to attend our Parent/Carer Conference on Saturday 15th November 2025 and hear the latest in medical research and news, as well as connect with other families in our community.